Fortrea Holdings Inc. FTRE Contract with Customer, Liability

Contract with Customer, Liability at other companies

Charles River LaboratoriesCRL

——

NeoGenomicsNEO

——

Flex Ltd.FLEX

——

ExlService HoldingsEXLS

——

Mirum Pharmaceuticals, Inc.MIRM

——

Other financials

Income statement

See full

Revenue$636.5M-2.3%

Gross profit$123.6M+6.1%

Operating income-$3.4M+99.3%

Net income-$23.6M+95.8%

EPS (diluted)-$0.25+96.0%

Balance sheet

See full

Cash & equivalents$147.5M+45.2%

Total debt$1.1B-13.1%

Total equity$525.9M-38.8%

Total assets$2.7B-14.0%

Cash flow

See full

Operating cash flow-$17.0M+86.3%

CapEx$8.0M+176%

Free cash flow-$25.0M+80.3%

Valuation

See full

Market cap$1.61B+29.3%

Enterprise value$2.58B-0.8%

P/S0.6×+0.1×

Profitability

See full

Gross margin18.9%-1.3pp

Operating margin-13.1%-4.1pp

Net margin-16.5%-5.0pp

FCF margin5.8%+1.7pp

Returns & leverage

See full

Return on equity-64.5%0.0pp

Debt / equity2.1×+0.6×

Current ratio0.9×0.0×

Where this comes from

Reported directly by Fortrea Holdings Inc. in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.

The official record: Fortrea Holdings Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fortrea Holdings Inc.'s contract with customer, liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Fortrea Holdings Inc.'s contract with customer, liability?: Fortrea Holdings Inc. (FTRE) reported contract with customer, liability of $3M in Q1 2025.